Literature DB >> 16386920

Comparison of Carpentier-Edwards pericardial and supraannular bioprostheses in aortic valve replacement.

John P A Puvimanasinghe1, Johanna J M Takkenberg, Marinus J C Eijkemans, Lex A van Herwerden, W R Eric Jamieson, Gary L Grunkemeier, J Dik F Habbema, Ad J J C Bogers.   

Abstract

OBJECTIVE: This study aimed at calculating and comparing the long-term outcomes of patients after aortic valve replacement with the Carpentier-Edwards bovine pericardial and porcine supraannular bioprostheses using microsimulation.
METHODS: We conducted a meta-analysis of eight studies on the Carpentier-Edwards pericardial valves (2,685 patients, 12,250 patient-years) and five studies on the supraannular valves (3,796 patients, 20,127 patient-years) to estimate the occurrence rates of valve-related events. Eighteen-year follow-up data sets were used to construct age-dependent Weibull curves that described their structural valvular deterioration. The estimates were entered into a microsimulation model, which was used to calculate the outcomes of patients after aortic valve replacement.
RESULTS: The annual hazard rates for thrombo-embolism after aortic valve replacement were 1.35% and 1.76% for the pericardial and supraannular valves, respectively. For a 65-year-old male, median time to structural valvular deterioration was 20.1 and 22.2 years while the lifetime risk of reoperation due to structural valvular deterioration was 18.3% and 14.0%, respectively. The life expectancy of the patient was 10.8 and 10.9 years and event-free life expectancy 9.0 and 8.8 years, respectively.
CONCLUSIONS: The microsimulation methodology provides insight into the prognosis of a patient after aortic valve replacement with any given valve type. Both the Carpentier-Edwards pericardial and supraannular valve types perform satisfactorily, especially in elderly patients, and show no appreciable difference in long-term outcomes when implanted in the aortic position.

Entities:  

Mesh:

Year:  2006        PMID: 16386920     DOI: 10.1016/j.ejcts.2005.11.037

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue.

Authors:  Leigh G Griffiths; Leila Choe; Kelvin H Lee; Kenneth F Reardon; E Christopher Orton
Journal:  Electrophoresis       Date:  2008-11       Impact factor: 3.535

2.  Aortic valve replacement with the Cardioprotese Premium bovine pericardium bioprosthesis: four-year clinical results.

Authors:  Fábio Rocha Farias; Francisco Diniz Affonso da Costa; Eduardo Mendel Balbi Filho; Daniele de Fátima Fornazari; Claudinei Collatusso; Andreia Dumsch de Aragon Ferreira; Sergio Veiga Lopes; Tadeu Augusto Fernandes
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-15

3.  Does preservation of the sub-valvular apparatus during mitral valve replacement affect long-term survival and quality of life? A Microsimulation Study.

Authors:  Christopher Rao; Jonathan Hart; Andre Chow; Fotios Siannis; Polyxeni Tsalafouta; Bari Murtuza; Ara Darzi; Frank C Wells; Thanos Athanasiou
Journal:  J Cardiothorac Surg       Date:  2008-04-23       Impact factor: 1.637

Review 4.  Contemporary outcomes after surgical aortic valve replacement with bioprostheses and allografts: a systematic review and meta-analysis.

Authors:  Simone A Huygens; Mostafa M Mokhles; Milad Hanif; Jos A Bekkers; Ad J J C Bogers; Maureen P M H Rutten-van Mölken; Johanna J M Takkenberg
Journal:  Eur J Cardiothorac Surg       Date:  2016-03-29       Impact factor: 4.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.